Technology breaks reduce cell phone use in college classrooms but have mixed results on academic performance, suggesting further investigation is needed.
Anti-CD38-Based Quadruplet Improves Outcomes in Transplant-Ineligible Myeloma
Daratumumab plus a standard triplet improved minimal residual disease negativity rates in patients with transplant-ineligible multiple myeloma. The quadruplet also improved rates of complete response